For glioblastoma, in the module of tumor proliferation and progression, the hub FSTL5, as a candidate gene for tumor-suppressor, encodes a secretory glycoprotein and its expression level is highly correlated with tumor size. The gene discussed is ART4; the disease is glioblastoma.